|
|
Volumn 8, Issue 7, 2009, Pages 523-524
|
|
Novel consortium to address shortfall in innovative medicines for psychiatric disorders
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
ARTICLE;
DEPRESSION;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG QUALITY;
DRUG SAFETY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
DRUG TARGETING;
EUROPEAN UNION;
HUMAN;
MEDICAL SOCIETY;
MENTAL DISEASE;
NEGATIVE SYNDROME;
POSITIVE SYNDROME;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
SCHIZOPHRENIA;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
DEPRESSION;
DISEASE MODELS, ANIMAL;
DRUG DISCOVERY;
HUMANS;
SCHIZOPHRENIA;
|
|
EID: 67650074908
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2939 Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|